MPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement Post author:GHIAA Admin Post published:September 4, 2024 Post category: Continue ReadingMPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement
BMS – MPP, HIV Antiretroviral (atazanavir – ATV) License and Technology Transfer Agreement Post author:GHIAA Admin Post published:September 4, 2024 Post category: Continue ReadingBMS – MPP, HIV Antiretroviral (atazanavir – ATV) License and Technology Transfer Agreement
Pfizer – MPP, TB Therapeutic (Sutezolid) Non-Exclusive License Agreement Post author:GHIAA Admin Post published:May 30, 2024 Post category: Continue ReadingPfizer – MPP, TB Therapeutic (Sutezolid) Non-Exclusive License Agreement
MPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement Post author:GHIAA Admin Post published:May 30, 2024 Post category: Continue ReadingMPP – Gates Medical Research Institute, TB therapeutic (Sutezolid) Sublicense Agreement
GARDP – Orchid, Cefiderocol Manufacturing Sublicense and Technology Transfer Agreement Post author:GHIAA Admin Post published:November 20, 2023 Post category: Continue ReadingGARDP – Orchid, Cefiderocol Manufacturing Sublicense and Technology Transfer Agreement
GARDP – Orchid, Cefiderocol Manufacturing Sublicense and Technology Transfer Agreement Post author:GHIAA Admin Post published:November 20, 2023 Post category: Continue ReadingGARDP – Orchid, Cefiderocol Manufacturing Sublicense and Technology Transfer Agreement
GARDP – Orchid, Cefiderocol Manufacturing Sublicense and Technology Transfer Agreement Post author:GHIAA Admin Post published:November 20, 2023 Post category: Continue ReadingGARDP – Orchid, Cefiderocol Manufacturing Sublicense and Technology Transfer Agreement
Medigen – MPP (C-TAP), COVID-19 Vaccine, Patent and Know How License Agreement Post author:GHIAA Admin Post published:October 11, 2023 Post category: Continue ReadingMedigen – MPP (C-TAP), COVID-19 Vaccine, Patent and Know How License Agreement
Merck – MPP, Molnupiravir License Agreement Post author:GHIAA Admin Post published:December 15, 2022 Post category: Continue ReadingMerck – MPP, Molnupiravir License Agreement